The invention involves administration of an immunostimulatory nucleic acid
alone or in combination with an asthma/allergy medicament for the
treatment or prevention of asthma and allergy in subjects. The
combination of drugs are administered in synergistic amounts or in
various dosages or at various time schedules. The invention also relates
to kits and compositions concerning the combination of drugs.